Oncology startup 4baseCare raises Rs 90 Cr led by Ashish Kacholia and Lashit Sanghvi

Precision oncology startup 4baseCare has raised Rs 90 crore ($9.8 million) in the first close of its Series B round co-led by Ashish Kacholia and Lashit Sanghvi, with participation from existing investor Yali Capital.

The new round comes after a gap of two years. In 2024, the company had raised $6 million in Series A funding, led by Yali Capital, with participation from Infosys.

The fresh capital will be used to expand 4baseCare’s hospital-linked genomics lab network across India, the Middle East, Southeast Asia, Latin America, and Central Asia. It will also scale its AI-powered precision oncology platform, OncoTwin, which supports clinical decision-making for cancer treatment.

Founded by Hitesh Goswami, 4baseCare focuses on building population-relevant clinico-genomic datasets to improve cancer diagnosis and treatment outcomes in underrepresented populations. Its platform integrates genomic testing with real-world clinical and outcomes data to generate actionable insights for oncologists.

The OncoTwin platform was recently selected for the MSK iHub program at Memorial Sloan Kettering Cancer Center, New York.

The company works closely with hospitals to offer genomics-led cancer diagnostics within clinical settings and is positioning itself to scale across emerging markets.

Investor interest in cancer-focused startups has picked up in recent years. Last year, Everhope Oncology raised $10 million in seed funding, and MOC Cancer Care & Research Centre secured $18 million led by Elevation Capital. ErlySign, OnCare, and OneCell Diagnostics are also among the funded startups.